Clinical Trials Logo

Allergy to House Dust Mite clinical trials

View clinical trials related to Allergy to House Dust Mite.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT04969653 Completed - Atopic Dermatitis Clinical Trials

The Incidence of Venous Thromboembolism in Atopic Dermatitis

Start date: June 21, 2021
Phase:
Study type: Observational

This study aims to investigate the incidence of venous thromboembolism in people who are diagnosed with atopic dermatitis.

NCT ID: NCT04673591 Completed - Allergic Asthma Clinical Trials

Effects of Tregalizumab on Allergen-induced Airway Responses and Airway Inflammation in Asthmatic Patients

Tregulaire
Start date: December 9, 2020
Phase: Phase 2
Study type: Interventional

The study will be conducted as a randomized, double-blind, placebo-controlled, single-center study in adult patients with mild controlled allergic asthma and house dust mite allergy.

NCT ID: NCT01275456 Completed - Clinical trials for Allergy to House Dust Mite

Validation of an Environmental Exposure Chamber for Inhalation Studies With House Dust Mite Allergen in Patients With Allergic Rhinitis

Start date: January 2011
Phase: N/A
Study type: Interventional

This clinical validation study is aimed at testing the efficacy of a new environmental challenge chamber (ECC) to induce symptoms of allergic rhinitis in patients allergic to house dust mite. The symptoms will be recorded on a validated symptom score as Total Nasal Symptom Score (TNSS), allowing for determine whether the challenge is dose dependent and reproducible.